State Ledger
Company profile

MUSTANG BIO, INC. CIK 1680048

Ticker
MBIO (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Waltham, MA 02453
Fiscal year end
2025 (FY)
Market Data
Close
$0.41
Change
-$0.03
Change %
-6.02%
Volume
1,458

MBIO · trading date Oct 12, 2026 · previous close $0.43 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$1.92M
Total assets
$17.59M
Total liabilities
$8.06M
Stockholders' equity
$9.53M
Cash & equivalents
$17.27M
Operating income
-$2.43M
Operating cash flow
-$5.26M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-19. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
45.8%
Equity / assets
54.2%
CapEx / revenue
—
Operating cash flow / net income
2.74×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$1.92M $17.59M $8.06M $9.53M
2024 — -$15.75M $9.31M $13.18M -$3.87M
2023 — -$51.60M $17.74M $17.62M $123.0K
2022 — -$77.53M $92.42M $46.15M $46.27M
2021 — -$66.37M $125.17M $12.77M $112.40M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-05
Financials filed via
Form 10-K
filed 2026-03-19

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Waltham, MA 02453
95 SAWYER RD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies